- Home
- SOLV
SOLV
SOLVENTUM CORP
as 03-25-2025 4:00pm EST
Stocks
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.
| Founded: | 2023 | Country: | United States |
| Employees: | N/A | City: | ST. PAUL |
| Market Cap: | 12.6B | IPO Year: | N/A |
| Target Price: | $79.86 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Hold | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.76 | EPS Growth: | -64.57 |
| 52 Week Low/High: | $47.16 - $96.05 | Next Earning Date: | 04-03-2025 |
| Revenue: | $8,254,000,000 | Revenue Growth: | 0.69% |
| Revenue Growth (this year): | 2.35% | Revenue Growth (next year): | 1.67% |
Latest SOLVENTUM CORP News
SOLV Breaking Stock News: Dive into SOLV Ticker-Specific Updates for Smart Investing
PR Newswire
6 days ago
Solventum to Present Value Creation Formula and Long-Range Plan at 2025 Investor Day
PR Newswire
9 days ago
Alger Russell Innovation Index Updates for First Quarter 2025
PR Newswire
14 days ago
Solventum Launches Attest™ eBowie-Dick Test System Revolutionizing Sterilization Assurance
PR Newswire
a month ago
Solventum Reports Fourth Quarter 2024 Financial Results and Introduces 2025 Full-Year Guidance
The Wall Street Journal
a month ago
Nelson Peltz’s Trian Pushes Solventum to Further Simplify Business
PR Newswire
a month ago
Solventum to Host Investor Day on Thursday, March 20, 2025, in New York City
Yahoo Finance Video
a month ago
Healthcare sector leading markets in 2025: What to know
GlobeNewswire
a month ago
Trian Comments on Solventum’s Sale of its Purification & Filtration Business
Compare SOLV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SOLV SOLVENTUM CORP - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.